1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Patient Registry Software Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Patient Registry Software Market, by Registry Type
8.1.1. Disease Registries
8.1.1.1. Market Revenue and Forecast
8.1.2. Health Service Registries
8.1.2.1. Market Revenue and Forecast
8.1.3. Population Registries
8.1.3.1. Market Revenue and Forecast
8.1.4. Product Registries
8.1.4.1. Market Revenue and Forecast
9.1. Patient Registry Software Market, by Software Type
9.1.1. Standalone Software
9.1.1.1. Market Revenue and Forecast
9.1.2. Integrated Software
9.1.2.1. Market Revenue and Forecast
10.1. Patient Registry Software Market, by Functionality
10.1.1. Population Health Management
10.1.1.1. Market Revenue and Forecast
10.1.2. Patient Care Management
10.1.2.1. Market Revenue and Forecast
10.1.3. Medical Research & Clinical Studies
10.1.3.1. Market Revenue and Forecast
10.1.4. Health Information Exchange
10.1.4.1. Market Revenue and Forecast
10.1.5. Point of Care
10.1.5.1. Market Revenue and Forecast
10.1.6. Product Outcome Evaluation
10.1.6.1. Market Revenue and Forecast
11.1. Patient Registry Software Market, by End User
11.1.1. Government agencies & public health authorities
11.1.1.1. Market Revenue and Forecast
11.1.2. Hospitals & Medical Practices
11.1.2.1. Market Revenue and Forecast
11.1.3. Private Payers
11.1.3.1. Market Revenue and Forecast
11.1.4. Pharmaceutical, Biotechnology & Medical Device Companies
11.1.4.1. Market Revenue and Forecast
11.1.5. Research Centers
11.1.5.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Registry Type
12.1.2. Market Revenue and Forecast, by Software Type
12.1.3. Market Revenue and Forecast, by Functionality
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Registry Type
12.1.5.2. Market Revenue and Forecast, by Software Type
12.1.5.3. Market Revenue and Forecast, by Functionality
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Registry Type
12.1.6.2. Market Revenue and Forecast, by Software Type
12.1.6.3. Market Revenue and Forecast, by Functionality
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Registry Type
12.2.2. Market Revenue and Forecast, by Software Type
12.2.3. Market Revenue and Forecast, by Functionality
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Registry Type
12.2.5.2. Market Revenue and Forecast, by Software Type
12.2.5.3. Market Revenue and Forecast, by Functionality
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Registry Type
12.2.6.2. Market Revenue and Forecast, by Software Type
12.2.6.3. Market Revenue and Forecast, by Functionality
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Registry Type
12.2.7.2. Market Revenue and Forecast, by Software Type
12.2.7.3. Market Revenue and Forecast, by Functionality
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Registry Type
12.2.8.2. Market Revenue and Forecast, by Software Type
12.2.8.3. Market Revenue and Forecast, by Functionality
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Registry Type
12.3.2. Market Revenue and Forecast, by Software Type
12.3.3. Market Revenue and Forecast, by Functionality
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Registry Type
12.3.5.2. Market Revenue and Forecast, by Software Type
12.3.5.3. Market Revenue and Forecast, by Functionality
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Registry Type
12.3.6.2. Market Revenue and Forecast, by Software Type
12.3.6.3. Market Revenue and Forecast, by Functionality
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Registry Type
12.3.7.2. Market Revenue and Forecast, by Software Type
12.3.7.3. Market Revenue and Forecast, by Functionality
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Registry Type
12.3.8.2. Market Revenue and Forecast, by Software Type
12.3.8.3. Market Revenue and Forecast, by Functionality
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Registry Type
12.4.2. Market Revenue and Forecast, by Software Type
12.4.3. Market Revenue and Forecast, by Functionality
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Registry Type
12.4.5.2. Market Revenue and Forecast, by Software Type
12.4.5.3. Market Revenue and Forecast, by Functionality
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Registry Type
12.4.6.2. Market Revenue and Forecast, by Software Type
12.4.6.3. Market Revenue and Forecast, by Functionality
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Registry Type
12.4.7.2. Market Revenue and Forecast, by Software Type
12.4.7.3. Market Revenue and Forecast, by Functionality
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Registry Type
12.4.8.2. Market Revenue and Forecast, by Software Type
12.4.8.3. Market Revenue and Forecast, by Functionality
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Registry Type
12.5.2. Market Revenue and Forecast, by Software Type
12.5.3. Market Revenue and Forecast, by Functionality
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Registry Type
12.5.5.2. Market Revenue and Forecast, by Software Type
12.5.5.3. Market Revenue and Forecast, by Functionality
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Registry Type
12.5.6.2. Market Revenue and Forecast, by Software Type
12.5.6.3. Market Revenue and Forecast, by Functionality
12.5.6.4. Market Revenue and Forecast, by End User
13.1. IBM Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. IQVIA Holdings Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Health Catalyst Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Oracle Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. UnitedHealth Group/Optum
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Conduent Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Elekta
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Dacima Software Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. ImageTrend Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Global Vision Technologies Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
